wfhss conf20070503 lecture07 en


What is the place for Hydrogen
peroxide plasma sterilisation in
hospital sterile supply?
Walter KOLLER, Univ.Prof., MD
Head, Clinical Division for Hospital Hygiene
Clin.Institute for Hygiene and Med. Microbiology
Medical University Vienna
WFHSS May 07 Baden 1
Background
Growing interest in easy-to-operate sterilisers for
complex medical devices (MD)
Simplicity and reliability claimed for Sterrad"!
hydrogen peroxide vapour (HPV) sterilisers
Conflicting results from different investigator teams
German/Austrian multicenter study warranted
restrictions for HPV-steriliser use in clinical settings
WFHSS May 07 Baden 2
Study protocol (1): authors
o Three STERRAD 100S sterilisers tested in
parallel with the same protocol in Vienna/A
1, 2
(two centres ) and Schwerin/Ge 3
1
KOLLER W, Clin.Div. Hospital Hygiene, Medical University Vienna, Austria
2 GETREUER H, Dept. for Hospital affairs, Vienna County, Austria
3 WERNER H P, Hyg-Cen, Schwerin, and KRAMER A, Dept. Hygiene and
Environmental Medicine, Ernst-Moritz-Arndt University, Greifswald, Germany
WFHSS May 07 Baden 3
Study protocol (2): micro lab
o 107/ml suspension of G. stearothermophilus dried
onto carriers and exposed to HPV sterilisation cycle
o Spore recovery from carriers by vortexing in CSB
and plating in serial dilutions on CSA
o Spore killing effect expressed as log reduction
calculated from exposed and unexposed carriers
o Each variation tested in triplicate
WFHSS May 07 Baden 4
Study protocol (3): variables
o Spore suspension media
o Carrier types
o Carrier wrapping
o Steriliser load size
o Steriliser cycle length
o Carrier position in steriliser chamber
WFHSS May 07 Baden 5
(1)
(1)
(1)
(1)
Legends to figures
LOG-REDuctions as LABoratories/
calculated after HPV Investigators (city):
exposure in Sterrad
" koller (Vienna)
" werner/Kramer
(LOG-RED = log cfubefore - log cfuafter)
(Schwerin/Greifswald)
" getreuer (Vienna)
SAL 10-6
= sterility assurance level
WFHSS May 07 Baden 6
(2)
(2)
(2)
(2)
Legends to figures
SPORe SUSPensions:
G.stearothermophilus-spores (~106/carrier) in:
napep isotonic saline + peptone
adest dest. water
WFHSS May 07 Baden 7
(3)
(3)
(3)
(3)
Legends to figures
EXPOSition of spores: carriers/devices
(wrap- and carrier-type):
PEhelix polyethylene-helix (fine mesh metal)
Methelix metal-helix (fine mesh metal)
Tyvekfol Tyvek-wrap (fine mesh metal)
WFHSS May 07 Baden 8
Wraps for fine mesh metal spore-carriers
Tyvekfol
PEhelix
Methelix
WFHSS May 07 Baden 9
WFHSS May 07 Baden 10
WFHSS May 07 Baden 11
Var s: spore suspensions and carriers/expositions
spore suspensions carriers/expositions
spore suspensions carriers/expositions
spore suspensions carriers/expositions
8
SAL 10-6
5
2
-1
8
5
2
Ä…Std. Dev.
Ä…Std. Err.
-1
Mean
kol wer get kol wer get kol wer get
EXPOS: EXPOS: EXPOS:
PEhelix Methelix Tyvekfol
WFHSS May 07 Baden 12
adest
SPORE SUSP:
LOG-RED
napep
SPORE SUSP:
General effect of position in dose/response curves on variances
response
max.
min.
low high
dose
WFHSS May 07 Baden 13
Effect of steriliser load size (spore suspension adest)
steriliser load size
steriliser load size
steriliser load size
8
5
2
-1
8
5
2
Ä…Std. Dev.
Ä…Std. Err.
-1
Mean
kol wer get kol wer get kol wer get
EXPOS: EXPOS: EXPOS:
PEhelix Methelix Tyvekfol
WFHSS May 07 Baden 14
small
load size:
LOG-RED
large
load size:
Effect of cycle length (spore suspension adest)
cycle length
cycle length
cycle length
8
5
2
-1
8
5
2
Ä…Std. Dev.
Ä…Std. Err.
-1
Mean
kol wer get kol wer get kol wer get
EXPOS: EXPOS: EXPOS:
PEhelix Methelix Tyvekfol
WFHSS May 07 Baden 15
half
cycle length:
LOG-RED
full
cycle length:
Effect of spore carrier position in steriliser (spore susp adest)
spore carrier position
spore carrier position
spore carrier position
9
7
5
3
1
-1
9
7
5
3
1
-1
9
7
5
3
Ä…Std. Dev.
1
Ä…Std. Err.
-1
Mean
1 2 3 4 5 6 7 8 910 1 2 3 4 5 6 7 8 910 1 2 3 4 5 6 7 8 910
EXPOS: EXPOS: EXPOS:
PEhelix Methelix Tyvekfol
WFHSS May 07 Baden 16
kol
LAB:
wer
LAB:
LOG-RED
get
LAB:
Conclusions from study 2000
Sterrad"! 100S only acceptable with significant
limitations:
o Absence of any organic or crystalline mini-residues
on surfaces
o Absence of long fine bore channels esp. in metallic
structures
o Steriliser load below critical limit
o Absence of cotton/cellulose and other organic
components in MD and wrap
Control and documentation of critical process
parameters urged!
WFHSS May 07 Baden 17
2007 status
New generation of STERRAD 100-S, NX and 200
systems equipped with process control and
documentation tools which allow validation.
In October 2006, a limited approval was issued by
the Austrian ministry of health (AMH) for these
STERRAD products. AMH Limitations for Sterrad"!
use in human medicine comprise:
o Compliance with EN ISO 14937:2000 mandatory for
use in medical settings (notably documentation and control of all
relevant process parameters with suitable and calibrated instruments)
o optimised and validated precleaning mandatory
WFHSS May 07 Baden 18
Limitations (cont.)
o exclusion of any MD which can be autoclaved
o exclusion of (invasive) MD equipped with hardly
accessible fine bores, joints, seams, grooves,
lamellae or grills
o STERRAD not accepted as alternative to EO- or
LTF-sterilisation unless suitability of and compatibility with MD in the
given clinical setting proven and on site validation successfully performed
o Specialised instrument wraps (Tyvec) and sealing
equipment as recommended by mfct. to be used in
any case.
WFHSS May 07 Baden 19
Recommendations
o New STERRAD 100-S, NX and 200 systems
recommended for MD which
- require sterilisation and
- are not intended for invasive use and
- do not require special manipulations in the process
steps preceding sterilisation
= exclusively for highly specialised procedures and
equipment !
o Specialised instrument wraps (Tyvec) and sealing
equipment must be budgeted when comparing with
other LT sterilising systems
WFHSS May 07 Baden 20
Conclusions
o HPV can act sporocidal at moderate temperatures (40 -
60°C) when high level cleanness and uninhibited access
of HPV is guaranteed.
o New STERRAD 100-S, NX and 200 systems are
equipped with process control and documentation tools
which allow validated sterilising processes,
o approved by the Austrian ministry of health as niche
products for sterilisation of highly selected MDs under
strictly controlled conditions (EN ISO 14937:2000).
o Specialised instrument wraps (Tyvec) and sealing
equipment are required.
WFHSS May 07 Baden 21


Wyszukiwarka

Podobne podstrony:
wfhss conf20070503 lecture29 en
wfhss conf20070503 lecture08 en
wfhss conf20070503 lecture30 en
wfhss conf20070503 lecture21 en
wfhss conf20091007 lecture sp s402 en
wfhss conf20100730 lecture sp s501 en
wfhss conf20100730 lecture sp s801 pt
wfhss workshop20071206 lecture03 en
wfhss workshop20061101 lecture09 en
iccaid conf20080327 lecture?2 en
wfhss workshop20061101 lecture14 en
fr?fh conf20080409 lecture00 en
wfhss workshop20071206 lecture05 en
wfhss conf20080604 lecture3b it
wfhss workshop20090325 lecture01 en
wfhss workshop20090325 lecture01 en
wfhss workshop20061101 lecture05 en
wfhss training 2 01 en
co?pce conf20070927 lecture?0 es

więcej podobnych podstron